Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001642380-26-000008
Filing Date
2026-05-13
Accepted
2026-05-13 16:15:10
Documents
66
Period of Report
2026-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q imdx-20260331.htm   iXBRL 10-Q 2482683
2 EX-31.1 imdx-ex31_1.htm EX-31.1 14773
3 EX-31.2 imdx-ex31_2.htm EX-31.2 14706
4 EX-32.1 imdx-ex32_1.htm EX-32.1 11080
  Complete submission text file 0001642380-26-000008.txt   11601935

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT imdx-20260331.xsd EX-101.SCH 1637587
70 EXTRACTED XBRL INSTANCE DOCUMENT imdx-20260331_htm.xml XML 2268032
Mailing Address 2 INTERNATIONAL PLAZA DR., SUITE 510 NASHVILLE TN 37217
Business Address 2 INTERNATIONAL PLAZA DR., SUITE 510 NASHVILLE TN 37217 949-409-7600
Insight Molecular Diagnostics Inc. (Filer) CIK: 0001642380 (see all company filings)

EIN.: 271041563 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37648 | Film No.: 26973450
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)